Components of equity [Axis] Share capital [Member] Share premium [Member] Foreign currency translation reserve [Member] Accumulated deficit [Member] Associates [axis] PolyHeal Ltd. [Member] Categories of related parties [axis] Employees, Officers and Members [Member] Counterparties [axis] BARDA [Member] Title of Individual [Axis] CEO [Member] Document And Entity Information Entity Registrant Name Entity Central Index Key Document Type Document Period End Date Amendment Flag Current Fiscal Year End Date Document Fiscal Period Focus Document Fiscal Year Focus Statement of financial position [abstract] CURRENT ASSETS: Cash and cash equivalents Restricted deposits Short-term bank deposits Trade receivables Inventories Other receivables CURRENT ASSETS, TOTAL LONG-TERM ASSETS: Property, plant and equipment, net Right of-use assets, net Intangible assets, net LONG-TERM ASSETS, TOTAL ASSETS, TOTAL CURRENT LIABILITIES: Current maturities of long-term liabilities Trade payables and accrued expenses Other payables CURRENT LIABILITIES, TOTAL LONG-TERM LIABILITIES: Deferred revenues Liability in respect of IIA grants Contingent consideration for purchase of shares Liability in respect of discontinued operation Lease liabilities Severance pay liabilities, net LONG TERM LIABILITIES, TOTAL SHAREHOLDERS' EQUITY: Ordinary shares of NIS 0.01 par value: Authorized: 50,000,000 shares as of June 30, 2020, December 31, 2019 and 37,244,508 shares as of June 30, 2019; Issued and Outstanding: 27,211,128 as of June 30, 2020, 27,202,795 as of December 31, 2019 and 27,178,839 as of June 30, 2019 Share premium Foreign currency translation adjustments Accumulated deficit SHAREHOLDERS' EQUITY, TOTAL LIABILITIES AND SHAREHOLDERS' EQUITY, TOTAL Ordinary shares, par value Ordinary shares, Authorized Ordinary shares, Issued Ordinary shares, Outstanding Profit or loss [abstract] Revenues from sale of products Revenues from development services Revenues from license agreements Total revenues Cost of revenues Gross profit Research and development, gross Participations by BARDA and IIA Research and development, net of participations Selling and marketing General and administrative Other expenses Total operating expenses Operating profit (loss) Financial income Financial expense Profit (loss) from continuing operation Profit from discontinued operation Net Profit (loss) Other comprehensive income (loss): Foreign currency translation adjustments Total comprehensive income (loss) Basic and diluted net profit (loss) per share from continuing operations Basic and diluted net profit (loss) per share from discontinued operations Total Basic and diluted net profit (loss) per share Weighted average number of ordinary shares used in the computation of basic and diluted loss per share (in thousands) Statement of changes in equity [table] Statement of changes in equity [line items] Components of equity [axis] Balance Accumulated effect of adopting new standard Balance Loss for the period Other comprehensive loss Exercise of warrants Exercise of options Purchase of treasury shares Share-based compensation Balance Statement of cash flows [abstract] Cash Flows from Operating Activities: Net Profit (loss) Adjustments to reconcile net profit (loss) to net cash provided by (used in) continuing operating activities: Adjustments to profit and loss items: Profit from discontinued operation Depreciation and amortization Share-based compensation Revaluation of liability in respect of IIA grants Revaluation of contingent consideration for the purchase of shares Revaluation of lease liabilities Increase (decrease) in severance pay liabilities, net Net financing income Un-realized foreign currency (gain) loss Adjustments to profit and loss items, total Changes in asset and liability items: Decrease (increase) in trade receivables Decrease (increase) in inventories Decrease (increase) in other receivables Increase (decrease) in trade payables and accrued expenses Increase in other payables and deferred revenues Changes in asset and liability items, total Net cash provided by (used in) continuing operating activities Net cash provided by (used in) discontinued operating activities Net cash provided by (used in) operating activities Cash Flows from Investing Activities: Purchase of property and equipment Interest received Proceeds from (investment in) short term bank deposits, net Net cash provided by (used in) continuing investing activities Net cash used in discontinued investing activities Net cash provided by (used in) investing activities Cash Flows from Financing Activities: Repayment of leases liabilities Proceeds from exercise of options Proceeds of IIA grant, net of repayments Net cash (used in) provided by financing activities Exchange rate differences on cash and cash equivalent balances Cash and cash equivalents: Increase in cash and cash equivalents from continuing activities Increase (decrease) in cash and cash equivalents from discontinued activities Balance of cash and cash equivalents at the beginning of the period Balance of cash and cash equivalents at the end of the period Disclosure of general [Abstract] GENERAL Disclosure of significant accounting policies [Abstract] SIGNIFICANT ACCOUNTING POLICIES Disclosure of contingent liabilities [abstract] CONTINGENT LIABILITIES AND COMMITMENTS Equity [abstract] EQUITY Significant Accounting Policies Basis of presentation of financial statements Basis of preparation of the interim consolidated financial statements Changes in significant accounting policies Functional currency, reporting currency and foreign currency Cash equivalents Short-term bank deposits Inventories Participation by governments support Leases Property, plant and equipment, net Intangible assets, net Revenue recognition Research and development expenses Impairment of non-financial assets Financial instruments Provisions Short-term employee benefits and severance pay liability, net Share-based compensation Discontinued operation Loss per share Reclassification Schedule of condensed interim consolidated statement of financial position Schedule of condensed interim consolidated statement of profit or loss Disclosure of associates [table] Disclosure of associates [line items] Ownership percentage Shares issued price in initial public offering Gross proceeds from initial public offering Underwriting discounts Shares issued expense Net proceeds from initial public offering Contract term Funding amount Procurement amount Additional funding amount Additional procurement amount Supplemental Funding Disclosure of detailed information about property, plant and equipment [table] Disclosure of detailed information about property, plant and equipment [line items] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] Increase of deferred revenues Increase of accumulated deficit Lease liability Incremental interest rates of lease liability Depreciation expenses right-of-use asset Finance expenses Lease expenses Statement Table [Table] Statement Line Items [Line Items] Options granted to purchase ordinary shares Options granted, exercise price Fair value of options Changes in asset and liability items, total. Adjustment for increase in other payables and deferred revenues. Adjustments [Member] BARDA [Member] BARDA [Member] CEO [Member] Contract term in years. Cumulative effect adjustment on accumulated deficit as a result of adopting IFRS 15. The description of the entity's accounting policy for short-term bank deposits. The description of accounting policies basis of preparation of the interim consolidated financial statements. The description of accounting policies changes in significant accounting policies. The disclosure of detailed information about condensed interim consolidated statement of financial position. The disclosure of detailed information about condensed interim consolidated statement of profit or loss. The amount of residual interest in the assets of the entity after deducting all its liabilities. 2014 Equity Incentive Plan (the "2014 Plan") [Member] Incremental interest rates of lease liability Lease expenses for the period. The net cash inflow from the issuing of ordinary shares. NexoBrid [Member] Noncurrent lease liability. Participations by BARDA and IIA PolyHeal Ltd. [Member] Additional funding amount. Additional procurement amount. Funding amount. Procurement amount. Research and development, gross Restricted Shares Unit [Member] Revaluation of lease liabilities Revaluation of liabilities in respect of IIA grants. Shares issued price in initial public offering. Stock Options [Member] Teva [Member] Underwriting discounts. Vericel [Member] Supplemental Funding. Employees, Officers and Members [Member] Proceeds from grants during the period. Current assets Non-current assets Assets Current liabilities Non-current liabilities Equity Equity and liabilities Revenue Gross profit Operating expense Profit (loss) from operating activities Finance costs Profit (loss) from continuing operations Reclassification adjustments on change in value of foreign currency basis spreads, net of tax Comprehensive income Basic and diluted earnings (loss) per share Equity1 Adjustments for share-based payments RevaluationOfLiabilitiesInRespectOfGrants RevaluationOfLeaseLiabilities Adjustments for finance income (cost) Foreign exchange gain (loss) Adjustments to reconcile profit (loss) AdjustmentsForChangesInIncreaseDecreaseInAssetAndLiabilityItems Cash flows from (used in) operating activities, continuing operations Cash flows from (used in) operating activities Purchase of property, plant and equipment, classified as investing activities Cash flows from (used in) investing activities, continuing operations Cash flows from (used in) investing activities Payments of lease liabilities, classified as financing activities Cash flows from (used in) financing activities Increase (decrease) in cash and cash equivalents DescriptionOfAccountingPolicyForShorttermBankDepositsExplanatory Description of accounting policy for measuring inventories [text block] Description of accounting policy for property, plant and equipment [text block] Description of accounting policy for intangible assets other than goodwill [text block] Description of accounting policy for share-based payment transactions [text block]